ISSN: 2376-0311

JBR Journal of Clinical Diagnosis and Research
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Case Report

Percutaneous Cryoablation for the Treatment of Renal Cell Carcinoma with Paraneoplastic Manifestations

May Jean Counsilman1, Michael J Amirian2, Colette M Shaw3 and Costas D Lallas2*

1Jefferson Medical College, Philadelphia, PA, USA

2Department of Urology, Thomas Jefferson University, Philadelphia, PA, USA

3Department of Radiology, Thomas Jefferson University, Philadelphia, PA, USA

Corresponding Author:
Lallas CD
Department of Urology
Thomas Jefferson University
Philadelphia, PA
Tel : (215) 955-6961
E-mail: Costas.lallas@jefferson.edu

Received date:June 20, 2014; Accepted date: August 25, 2014; Published date: September 02,2014

Citation: Counsilman MJ, Amirian MJ, Shaw CM, Lallas CD (2014) Percutaneous Cryoablation for the Treatment of Renal Cell Carcinoma with Paraneoplastic Manifestations. J Clin Diagn Res 2:109. doi:10.4172/2376-0311.1000109

Copyright: 2014 Counsilman MJ, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

We report on a patient who presented with severe myoclonus as a paraneoplastic syndrome due to a renal cell carcinoma. In a patient who had contraindications against definitive extirpative surgery, this is the first instance in which percutaneous cryoablation was used as a successful treatment for the renal cell carcinoma and neurological manifestations.

Keywords

Top